drugset / Trial / NCT01171105

Study to Investigate Multiple Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects

NCT01171105

Phase 1 Completed 73 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

1. The main purpose of this study is to assess the safety and tolerability of AZD5213 after multiple oral doses. 2. Another purpose of this study is to evaluate the pharmacokinetics (also called PK - how the study drug enters and leaves your body and how your body acts on the study drug) of AZD5213 in your blood and urine.

Timeline

Start
2010-07
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5213 Unknown Oral

Indications

No indication recorded.